The impact of gut microbiota on leukemia and prospects for novel therapies
Infectious Medicine · 2026-03 · 5 (1) · 100239
DOI: 10.1016/j.imj.2026.100239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infectious Medicine, 2026-03. Verfasst von Saba Jalalifar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran 1593716615, …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran University of Medical Sciences.
Abstract (Originalsprache)
The Human Microbiome Project has underscored the pivotal role of the gut microbiome in human health, revealing its potential influence on leukemia development, progression, and treatment response. This review summarizes evidence on microbiome-targeted therapies such as probiotics, fecal microbiota transplantation, antimicrobial peptides, and nanoparticles. These approaches may improve leukemia treatment outcomes through immune and metabolic modulation and reduced toxicity. Although emerging data suggest beneficial effects, most findings remain correlative and limited by small, heterogeneous studies. Further mechanistic and clinical research is required to clarify causal pathways, standardize interventions, and evaluate long-term safety. Personalized microbiome-based strategies that integrate molecular and immunologic profiling may ultimately refine leukemia management and improve survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran 1593716615, Iran.
- Mehresoheila Cancer Charity, Alborz 3139954344, Iran.
- School of Medicine, Alborz University of Medical Sciences, Karaj 3149779453, Iran.
- Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran 1593716615, Iran.
- Department of Medical Library and Information Science, School of Health Management and Information Science, Iran University of Medical Science, Tehran 1449614535, Iran.
- Venom and Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran.
Förderung
- Iran University of Medical Sciences
Zitieren
APA
Jalalifar, S., Bajelan, B., Mohammadi, R., Ghafoury, R., Kalhori, Z., Pooshang-Bagheri, K., Nekouian, R., & Faranoush, M. (2026). The impact of gut microbiota on leukemia and prospects for novel therapies. Infectious Medicine, 5(1), 100239. https://doi.org/10.1016/j.imj.2026.100239
Vancouver
Jalalifar S, Bajelan B, Mohammadi R, Ghafoury R, Kalhori Z, Pooshang-Bagheri K, et al. The impact of gut microbiota on leukemia and prospects for novel therapies. Infectious Medicine. 2026;5(1):100239. doi:10.1016/j.imj.2026.100239
BibTeX
@article{Jalalifar2026,
author = {Jalalifar, Saba and Bajelan, Bahar and Mohammadi, Reihane and Ghafoury, Roya and Kalhori, Zahra and Pooshang-Bagheri, Kamran and Nekouian, Reza and Faranoush, Mohammad},
title = {The impact of gut microbiota on leukemia and prospects for novel therapies},
journal = {Infectious Medicine},
year = {2026},
volume = {5},
number = {1},
pages = {100239},
doi = {10.1016/j.imj.2026.100239}
}
EUVIMED